TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,669
|
1,511
|
1,680 |
Financial expenses |
2
![]() |
2
|
1 |
Earnings before taxes |
483
|
354
|
576 |
EBITDA |
484
|
356
|
576 |
Total assets |
928
|
780
|
935 |
Current assets |
928
|
780
|
935 |
Current liabilities |
5
|
61
|
159 |
Equity capital |
804
|
627
|
705 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
86.6%
|
80.4%
|
75.4% |
Turnover per employee |
834
|
756
|
840 |
Profit as a percentage of turnover |
28.9%
|
23.4%
|
34.3% |
Return on assets (ROA) |
52.3%
|
45.6%
|
61.7% |
Current ratio |
18560.0%
|
1278.7%
|
588.1% |
Return on equity (ROE) |
60.1%
|
56.5%
|
81.7% |
Change turnover |
158
|
-169
|
-103 |
Change turnover % |
10%
|
-10%
|
-6% |
Chg. No. of employees |
0
![]() |
0
|
2 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.